Literature DB >> 34269838

SIRT1 single-nucleotide polymorphisms are associated with corticosteroid sensitivity in primary immune thrombocytopenia patients.

Shuwen Wang1, Xiaoyu Zhang1, Shaoqiu Leng1, Yanqi Zhang2, Ju Li2, Jun Peng1,3, Zeping Zhou4, Qi Feng5, Xiang Hu6.   

Abstract

BACKGROUND: Primary immune thrombocytopenia (ITP) is an autoimmune disorder characterized by decreased platelet count. While corticosteroids are a useful first-line therapy for ITP patients, their long-term effectiveness is limited, and the determinants of corticosteroid sensitivity in ITP patients remain largely unknown. Sirtuin 1 (SIRT1), a member of the mammalian sirtuin family, is related to the anti-inflammatory effects of corticosteroids. Here, we investigate the contribution of the SIRT1 single-nucleotide polymorphisms (SNPs) rs12778366 and rs4746720 to ITP susceptibility.
METHODS: We recruited 330 ITP patients and 309 healthy controls from Han population, and performed genotyping of SIRT1 rs12778366 and rs4746720 using a MassARRAY system. The results were validated in another 55 ITP patients from ethnic minorities.
RESULTS: Using clinical data of patients and controls from Han polulation, including corticosteroid sensitivity, susceptibility, refractoriness, and severity, our results revealed that the CC/TC genotypes of SIRT1 rs12778366 were associated with a 2.034-fold increased risk of corticosteroid resistance compared to the homozygous major TT genotype (dominant, CC/TC vs. TT, OR = 2.034, 95% CI = 1.039-3.984, p = 0.038). In contrast, the CC/CT genotype of SIRT1 rs4746720 showed a 0.560-fold decreased risk of corticosteroid resistance (dominant, 95% CI = 0.321-0.976, OR = 0.560, p = 0.041). The C allele substitute in SIRT1 rs12778366 was significantly associated with the corticosteroid sensitivity of ITP patients (p = 0.021). The similar results were obtained in minority ITP patients.
CONCLUSION: This study indicates that SIRT1 rs12778366 and rs4746720 may be genetic factors related to corticosteroid sensitivity in ITP patients.
© 2021. The Author(s), under exclusive licence to Springer-Verlag GmbH Germany, part of Springer Nature.

Entities:  

Keywords:  Corticosteroid sensitivity; Primary immune thrombocytopenia; SIRT1; Single-nucleotide polymorphism

Year:  2021        PMID: 34269838     DOI: 10.1007/s00277-021-04583-z

Source DB:  PubMed          Journal:  Ann Hematol        ISSN: 0939-5555            Impact factor:   3.673


  44 in total

1.  Correction of abnormal T cell subsets by high-dose dexamethasone in patients with chronic idiopathic thrombocytopenic purpura.

Authors:  Jianqin Li; Zhaoyue Wang; Shaoyan Hu; Xiaojuan Zhao; Lijuan Cao
Journal:  Immunol Lett       Date:  2013-08-28       Impact factor: 3.685

2.  Initial treatment of immune thrombocytopenic purpura with high-dose dexamethasone.

Authors:  Yunfeng Cheng; Raymond S M Wong; Yannie O Y Soo; Chung Hin Chui; Fung Yi Lau; Natalie P H Chan; Wai Shan Wong; Gregory Cheng
Journal:  N Engl J Med       Date:  2003-08-28       Impact factor: 91.245

3.  High-dose dexamethasone vs prednisone for treatment of adult immune thrombocytopenia: a prospective multicenter randomized trial.

Authors:  Yu Wei; Xue-bin Ji; Ya-wen Wang; Jing-xia Wang; En-qin Yang; Zheng-cheng Wang; Yu-qi Sang; Zuo-mu Bi; Cui-ai Ren; Fang Zhou; Guo-qiang Liu; Jun Peng; Ming Hou
Journal:  Blood       Date:  2015-10-19       Impact factor: 22.113

Review 4.  How I treat immune thrombocytopenia: the choice between splenectomy or a medical therapy as a second-line treatment.

Authors:  Waleed Ghanima; Bertrand Godeau; Douglas B Cines; James B Bussel
Journal:  Blood       Date:  2012-06-26       Impact factor: 22.113

5.  [Pyeloureteral stenosis in the infant].

Authors:  C Miguelez Lago; C García Lorenzo; E Galiano Duro; G López Pérez
Journal:  Actas Urol Esp       Date:  1983 Jan-Feb       Impact factor: 0.994

6.  High-dose dexamethasone or all-trans-retinoic acid restores the balance of macrophages towards M2 in immune thrombocytopenia.

Authors:  Q Feng; M Xu; Y Y Yu; Y Hou; X Mi; Y X Sun; S Ma; X Y Zuo; L L Shao; M Hou; X H Zhang; J Peng
Journal:  J Thromb Haemost       Date:  2017-08-05       Impact factor: 5.824

7.  Inhaled steroids associated with decreased macrophage markers in nonasthmatic individuals with sickle cell disease in a randomized trial.

Authors:  Arielle L Langer; Andrew Leader; Seunghee Kim-Schulze; Yelena Ginzburg; Miriam Merad; Jeffrey Glassberg
Journal:  Ann Hematol       Date:  2019-02-20       Impact factor: 3.673

Review 8.  Clinical updates in adult immune thrombocytopenia.

Authors:  Michele P Lambert; Terry B Gernsheimer
Journal:  Blood       Date:  2017-04-17       Impact factor: 22.113

9.  High-dose dexamethasone corrects impaired myeloid-derived suppressor cell function via Ets1 in immune thrombocytopenia.

Authors:  Yu Hou; Qi Feng; Miao Xu; Guo-Sheng Li; Xue-Na Liu; Zi Sheng; Hai Zhou; Ji Ma; Yu Wei; Yuan-Xin Sun; Ying-Yi Yu; Ji-Hua Qiu; Lin-Lin Shao; Xin-Guang Liu; Ming Hou; Jun Peng
Journal:  Blood       Date:  2016-01-07       Impact factor: 22.113

Review 10.  High-dose dexamethasone compared with prednisone for previously untreated primary immune thrombocytopenia: a systematic review and meta-analysis.

Authors:  Siraj Mithoowani; Kathleen Gregory-Miller; Jennifer Goy; Matthew C Miller; Grace Wang; Nastaran Noroozi; John G Kelton; Donald M Arnold
Journal:  Lancet Haematol       Date:  2016-09-16       Impact factor: 18.959

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.